Call +44 (0)1904 798634 or +44 (0)7550 079918

Leading provider of life science market reports and research services

Hepatitis Viruses Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

Be the first to review this product

Hepatitis Viruses Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, 'Hepatitis Viruses Diagnostic Tests - Medical Devices Pipeline...
You can choose to pay by purchase order during checkout

Availability: In stock

$4,000.00

* Required Fields

You can choose to pay by purchase order during checkout
GlobalData.

Digital downloads direct to your inbox within 24 hours.

First class customer service from our team of experts.

Pay by credit card or request an invoice

Product Description

Details

Hepatitis Viruses Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, 'Hepatitis Viruses Diagnostic Tests - Medical Devices Pipeline Assessment, 2016' provides an overview of Hepatitis Viruses Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hepatitis Viruses Diagnostic Tests pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Hepatitis Viruses Diagnostic Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Hepatitis Viruses Diagnostic Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Hepatitis Viruses Diagnostic Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date

Additional Information

Additional Information

Publisher name GlobalData.
Format PDF
Page count 258
Publication date 1 Dec 2016
Table of contents 1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 15
2 Introduction 16
2.1 Hepatitis Viruses Diagnostic Tests Overview 16
3 Products under Development 17
3.1 Hepatitis Viruses Diagnostic Tests - Pipeline Products by Stage of Development 17
3.2 Hepatitis Viruses Diagnostic Tests - Pipeline Products by Territory 18
3.3 Hepatitis Viruses Diagnostic Tests - Pipeline Products by Regulatory Path 19
3.4 Hepatitis Viruses Diagnostic Tests - Pipeline Products by Estimated Approval Date 20
4 Hepatitis Viruses Diagnostic Tests - Pipeline Products under Development by Companies 22
4.1 Hepatitis Viruses Diagnostic Tests Companies - Pipeline Products by Stage of Development 22
4.2 Hepatitis Viruses Diagnostic Tests - Pipeline Products by Stage of Development 25
5 Hepatitis Viruses Diagnostic Tests Companies and Product Overview 30
5.1 Abbott Diagnostics Diagnostic Tests Company Overview 30
5.1.1 Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 30
5.2 Access Bio, Inc. Company Overview 34
5.2.1 Access Bio, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34
5.3 Alderon Biosciences, Inc. Company Overview 35
5.3.1 Alderon Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 35
5.4 Alere Inc Company Overview 36
5.4.1 Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 36
5.5 AutoGenomics Inc Company Overview 38
5.5.1 AutoGenomics Inc Pipeline Products & Ongoing Clinical Trials Overview 38
5.6 AXO Science SAS Company Overview 40
5.6.1 AXO Science SAS Pipeline Products & Ongoing Clinical Trials Overview 40
5.7 BCR Corp Company Overview 42
5.7.1 BCR Corp Pipeline Products & Ongoing Clinical Trials Overview 42
5.8 Beckman Coulter Inc Company Overview 44
5.8.1 Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 44
5.9 Biokit, S.A. Company Overview 48
5.9.1 Biokit, S.A. Pipeline Products & Ongoing Clinical Trials Overview 48
5.10 Biomagnetics Diagnostics Corporation (Inactive) Company Overview 51
5.10.1 Biomagnetics Diagnostics Corporation (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 51
5.11 Bio-Rad Laboratories Inc Company Overview 52
5.11.1 Bio-Rad Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 52
5.12 CeMines, Inc. Company Overview 54
5.12.1 CeMines, Inc. Pipeline Products & Ongoing Clinical Trials Overview 54
5.13 Cepheid Company Overview 56
5.13.1 Cepheid Pipeline Products & Ongoing Clinical Trials Overview 56
5.14 China Medical Technologies Inc (Inactive) Company Overview 58
5.14.1 China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 58
5.15 Co-Diagnostics HBDC, Inc. Company Overview 60
5.15.1 Co-Diagnostics HBDC, Inc. Pipeline Products & Ongoing Clinical Trials Overview 60
5.16 Corgenix Medical Corp Company Overview 61
5.16.1 Corgenix Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 61
5.17 Da An Gene Co Ltd Company Overview 62
5.17.1 Da An Gene Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 62
5.18 Diagnostics for the Real World (Europe) Ltd. Company Overview 66
5.18.1 Diagnostics for the Real World (Europe) Ltd. Pipeline Products & Ongoing Clinical Trials Overview 66
5.19 DiaSorin S.p.A Company Overview 67
5.19.1 DiaSorin S.p.A Pipeline Products & Ongoing Clinical Trials Overview 67
5.20 D-Kimia, LLC. Company Overview 71
5.20.1 D-Kimia, LLC. Pipeline Products & Ongoing Clinical Trials Overview 71
5.21 Ecoli s.r.o. Company Overview 72
5.21.1 Ecoli s.r.o. Pipeline Products & Ongoing Clinical Trials Overview 72
5.22 Enzo Biochem Inc Company Overview 85
5.22.1 Enzo Biochem Inc Pipeline Products & Ongoing Clinical Trials Overview 85
5.23 Fast-track diagnostics S.a.r.l. Company Overview 87
5.23.1 Fast-track diagnostics S.a.r.l. Pipeline Products & Ongoing Clinical Trials Overview 87
5.24 Ferrer inCode SL Company Overview 92
5.24.1 Ferrer inCode SL Pipeline Products & Ongoing Clinical Trials Overview 92
5.25 French National Institute of Health and Medical Research Company Overview 93
5.25.1 French National Institute of Health and Medical Research Pipeline Products & Ongoing Clinical Trials Overview 93
5.26 genedrive plc Company Overview 94
5.26.1 genedrive plc Pipeline Products & Ongoing Clinical Trials Overview 94
5.27 Genera Biosystems Ltd Company Overview 96
5.27.1 Genera Biosystems Ltd Pipeline Products & Ongoing Clinical Trials Overview 96
5.28 GenMark Diagnostics Inc Company Overview 98
5.28.1 GenMark Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 98
5.29 Goodgene Inc Company Overview 100
5.29.1 Goodgene Inc Pipeline Products & Ongoing Clinical Trials Overview 100
5.30 Hologic Inc Company Overview 102
5.30.1 Hologic Inc Pipeline Products & Ongoing Clinical Trials Overview 102
5.31 Imperial College London Company Overview 105
5.31.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 105
5.32 MedMira Inc. Company Overview 107
5.32.1 MedMira Inc. Pipeline Products & Ongoing Clinical Trials Overview 107
5.33 Mindray Medical International Ltd Company Overview 109
5.33.1 Mindray Medical International Ltd Pipeline Products & Ongoing Clinical Trials Overview 109
5.34 MND Diagnostic LTD Company Overview 118
5.34.1 MND Diagnostic LTD Pipeline Products & Ongoing Clinical Trials Overview 118
5.35 Molbio Diagnostics Pvt. Ltd. Company Overview 119
5.35.1 Molbio Diagnostics Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 119
5.36 NanoDiagX Company Overview 120
5.36.1 NanoDiagX Pipeline Products & Ongoing Clinical Trials Overview 120
5.37 OPKO Health Inc Company Overview 121
5.37.1 OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview 121
5.38 Orangelife Company Overview 123
5.38.1 Orangelife Pipeline Products & Ongoing Clinical Trials Overview 123
5.39 Pathogenica Inc Company Overview 124
5.39.1 Pathogenica Inc Pipeline Products & Ongoing Clinical Trials Overview 124
5.40 ProteinLogic Ltd Company Overview 126
5.40.1 ProteinLogic Ltd Pipeline Products & Ongoing Clinical Trials Overview 126
5.41 Qiagen NV Company Overview 127
5.41.1 Qiagen NV Pipeline Products & Ongoing Clinical Trials Overview 127
5.42 Quotient Limited Company Overview 129
5.42.1 Quotient Limited Pipeline Products & Ongoing Clinical Trials Overview 129
5.43 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Company Overview 131
5.43.1 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Pipeline Products & Ongoing Clinical Trials Overview 131
5.44 Roche Diagnostics International Ltd Company Overview 132
5.44.1 Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview 132
5.45 Sansure Biotech Inc Company Overview 141
5.45.1 Sansure Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 141
5.46 Siemens Healthcare GmbH Company Overview 145
5.46.1 Siemens Healthcare GmbH Pipeline Products & Ongoing Clinical Trials Overview 145
5.47 Stanford University Company Overview 151
5.47.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 151
5.48 Syamala Srinivasa Life Sciences Pvt. Ltd Company Overview 152
5.48.1 Syamala Srinivasa Life Sciences Pvt. Ltd Pipeline Products & Ongoing Clinical Trials Overview 152
5.49 The University of British Columbia Company Overview 154
5.49.1 The University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview 154
5.50 University Medical Center Hamburg-Eppendorf Company Overview 155
5.50.1 University Medical Center Hamburg-Eppendorf Pipeline Products & Ongoing Clinical Trials Overview 155
5.51 University of Texas Medical Branch at Galveston Company Overview 156
5.51.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 156
5.52 University of Warwick Company Overview 157
5.52.1 University of Warwick Pipeline Products & Ongoing Clinical Trials Overview 157
5.53 Ustar Biotechnologies (Hangzhou) Ltd. Company Overview 159
5.53.1 Ustar Biotechnologies (Hangzhou) Ltd. Pipeline Products & Ongoing Clinical Trials Overview 159
5.54 Xiamen Zeesan Biotech Co.,Ltd Company Overview 161
5.54.1 Xiamen Zeesan Biotech Co.,Ltd Pipeline Products & Ongoing Clinical Trials Overview 161
6 Hepatitis Viruses Diagnostic Tests- Recent Developments 162
6.1 Nov 15, 2016: OraSure Technologies Appoints Stephen S. Tang, Ph.D. as Chairman of the Board of Directors 162
6.2 Nov 10, 2016: Hologic Obtains Canadian Approval for Aptima Hepatitis C Quant Assay 162
6.3 Nov 10, 2016: Hologic Obtains Canadian Approval for Aptima Hepatitis B Quant Assay 163
6.4 Nov 09, 2016: Trovagene Reports Third Quarter 2016 Financial Results and Accomplishments 164
6.5 Nov 07, 2016: OPKO Health Reports Third Quarter Financial and Operating Results 165
6.6 Nov 04, 2016: Alere Reports Third Quarter 2016 Financial Results 166
6.7 Nov 03, 2016: GenMark Diagnostics Reports Q3 Financial Results 166
6.8 Nov 02, 2016: Quotient Announces CFO Transition 167
6.9 Nov 02, 2016: QIAGEN Reports Results for Third Quarter and First Nine Months of 2016 167
6.10 Nov 02, 2016: Hologic Announces Financial Results for Fourth Quarter of Fiscal 2016 170
6.11 Nov 02, 2016: OraSure Announces 2016 Third Quarter Financial Results 172
6.12 Nov 01, 2016: Bio-Rad Reports Third-Quarter Currency-Neutral Revenue Growth of 9.1 Percent 173
6.13 Oct 31, 2016: Quotient Second Quarter Fiscal 2017 Financial Results 174
6.14 Oct 31, 2016: Quotient Reports Continued Progress on the Commercial Scale-up of MosaiQ and Second Quarter Fiscal 2017 Financial Results 176
6.15 Oct 26, 2016: Laboratory Corporation of America Holdings Announces 2016 Third Quarter Results and Updates 2016 Guidance 178
6.16 Oct 20, 2016: bioMerieux-Business Review for the nine months ended September 30, 2016 180
6.17 Oct 19, 2016: Abbott Reports Third-Quarter 2016 Results 182
6.18 Oct 14, 2016: Quotient Raises USD84 million in First Tranche of Private Placement of 12% Notes Due 2023 185
6.19 Oct 13, 2016: General Biologicals to Raise up to USD10.2 Million in Public Offering of Shares 185
6.20 Oct 13, 2016: Enzo Biochem Reports Strong 2016 Operating Results 186
6.21 Oct 11, 2016: Genedrive Announces Preliminary Results for the year ended 30 June 2016 188
6.22 Sep 21, 2016: Genedrive Announces Appointment of Chief Financial Officer 193
6.23 Sep 20, 2016: LabCorp Names Veteran Biopharma Executive John Ratliff CEO of Covance Drug Development 194
6.24 Sep 13, 2016: OPKO Health Appoints Jane Pine Wood as Chief Legal and Compliance Officer of BioReference Laboratories 194
6.25 Sep 06, 2016: Alere Reports Second Quarter 2016 Financial Results 195
6.26 Sep 02, 2016: Danaher Acquires Cepheid 195
6.27 Aug 31, 2016: bioMerieux - First-Half 2016 Results 196
6.28 Aug 30, 2016: DiaSorin Enters into Agreement with Beckman Coulter 199
6.29 Aug 17, 2016: Alere Reports First Quarter 2016 Financial Results 200
6.30 Aug 08, 2016: Quotient Reports Further Progress on the Commercial Scale-up of MosaiQ and First Quarter Fiscal 2017 Financial Results 200
6.31 Aug 08, 2016: OPKO Health Reports Improved Financial and Operating Results 202
6.32 Aug 08, 2016: Alere Files Form 10-K, Reports Fourth Quarter and Full Year 2015 Financial Results 203
6.33 Aug 04, 2016: Trovagene Reports Second Quarter 2016 Financial Results and Accomplishments 205
6.34 Aug 04, 2016: Diasorin Group Revenues And EBITDA Reached Record highs In the Second Quarter 2016 206
6.35 Aug 03, 2016: Bio-Rad Reports Second-Quarter 2016 Financial Results 209
6.36 Aug 03, 2016: OraSure Announces 2016 Second Quarter Financial Results 210
6.37 Jul 28, 2016: Vela Diagnostics

Reviews

Write Your Own Review

Only registered users can write reviews. Please, log in or register

Product Tags

Product Tags

Use spaces to separate tags. Use single quotes (') for phrases.